Hiroki Mizuno

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Polycystic Kidney Disease

Rheumatoid Arthritis Patients

Top Venues

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Yoshimura, Masayuki Yamanouchi, Hiroki Mizuno, Daisuke Ikuma, Ryo Koizumi, Shigekazu Kurihara, Yuki Oba, Tatsuya Suwabe, Yuichiro Sawada, Hisashi Kamido, Hisashi Sugimoto, Masato Mizuta, Akinari Sekine, Eiko Hasegawa, Yoshifumi Ubara, Naoki Sawa
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease. Annals of the rheumatic diseases (2024)
Hiroki Mizuno, Whitney Besse, Akinari Sekine, Kelly T Long, Shigekazu Kurihara, Yuki Oba, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Naoki Sawa, Yoshifumi Ubara, Stefan Somlo, Junichi Hoshino
Genetic Analysis of Severe Polycystic Liver Disease in Japan. Kidney360 (2024)
Hiroki Mizuno, Whitney Besse, Akinari Sekine, Kelly T Long, Shigekazu Kurihara, Yuki Oba, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Naoki Sawa, Yoshifumi Ubara, Stefan Somlo, Junichi Hoshino
Genetic Analysis of Severe Polycystic Liver Disease in Japan. Kidney360 (2024)
Hiroki Mizuno, Whitney Besse, Akinari Sekine, Kelly T Long, Shigekazu Kurihara, Yuki Oba, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Naoki Sawa, Yoshifumi Ubara, Stefan Somlo, Junichi Hoshino
Genetic Analysis of Severe Polycystic Liver Disease in Japan. Kidney360 5 (8) (2024)
Hiroki Mizuno, Whitney Besse, Akinari Sekine, Kelly T Long, Shigekazu Kurihara, Yuki Oba, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Naoki Sawa, Yoshifumi Ubara, Stefan Somlo, Junichi Hoshino
Genetic Analysis of Severe Polycystic Liver Disease in Japan. Kidney360 5 (8) (2024)
Hiroki Mizuno, Akinari Sekine, Tatsuya Suwabe, Daisuke Ikuma, Masayuki Yamanouchi, Eiko Hasegawa, Naoki Sawa, Yoshifumi Ubara, Junichi Hoshino
Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use. PloS one 17 (2) (2022)